Billets de Michelle Dawson

Billet publié sur Twitter/X le 05/08/2022 10:47

Twitter/X Publication avec DOI crossref Extrait cité dans le billet Lien intégré au billet Termes sur l’autisme

1 réponse intégrée de Michelle Dawson

05/08/2022 10:49

Another note: re "adolescents" currently in this paper's title, the oldest included autistic is 7 years old (per Table 1), and "a maximum mean participant age of 60 months (i.e., 5 years)" is among the study inclusion criteria

Voir la réponse sur Twitter/X

Liens cités structurés

1 ressource citée

Publication avec DOI Récupéré Publication crossref

Gro Janne H. Wergeland, Maj-Britt Posserud, Krister Fjermestad, Urdur Njardvik, Lars-Göran Öst (2022). Early behavioral interventions for children and adolescents with autism spectrum disorder in routine clinical care: A systematic review and meta-analysis.. Clinical Psychology: Science and Practice, 29(4), 400-414. American Psychological Association (APA).

Date de publication
décembre 2022
Identifiant
10.1037/cps0000106
Auteurs
Gro Janne H. Wergeland, Maj-Britt Posserud, Krister Fjermestad, Urdur Njardvik, Lars-Göran Öst
Source
Clinical Psychology: Science and Practice
Détails
29(4), 400-414
Type de référence
article
Éditeur
American Psychological Association (APA)
Source de métadonnées
crossref

Résumé

The current paper systematically reviews and meta-analyses the effectiveness of early behavioral interventions (BI) for children with autism spectrum disorder (ASD) in routine clinical care. The effectiveness of BI, methodological study quality, and moderators of treatment outcome were examined and benchmarked with efficacy studies. The quality of the evidence was assessed with the Cochrane risk of bias tool. Twenty-nine studies were included, comprising 1,422 participants. Medium to large within-group effect sizes (g = 0.76–1.27) were found post-treatment for the outcome domains adaptive behavior, cognition, communication, and socialization, with large average effect size at post (g = 0.94) and at follow-up (g = 1.08). Comparison of effectiveness and efficacy studies showed that evidence-based early BI in routine clinical care yielded effects comparable to university research settings. The limitations include potential language and publication bias. The findings support evidence-based behavioral treatments delivered in routine clinical care as efficacious in reducing ASD symptoms. PROSPERO registration: ID CRD42020212833.

Auteur·ices de l’étude dans cette référence citée